U.S. v. Carilion Health System, 89-2625

Citation892 F.2d 1042
Decision Date02 October 1989
Docket NumberNo. 89-2625,89-2625
Parties1989-2 Trade Cases P 68,859 NOTICE: Fourth Circuit I.O.P. 36.6 states that citation of unpublished dispositions is disfavored except for establishing res judicata, estoppel, or the law of the case and requires service of copies of cited unpublished dispositions of the Fourth Circuit. UNITED STATES of America, v. CARILION HEALTH SYSTEM; Community Hospital of Roanoke Valley; Lewis-Gale Hospital, Inc,; Voluntary Hospitals of America, Inc.; American Medical Association, Amici Curiae. . Argued:
CourtUnited States Courts of Appeals. United States Court of Appeals (4th Circuit)

John Paul Fonte (Robert B. Nicholson; James F. Rill, Assistant Attorney General; Judy Whaley, Deputy Assistant Attorney General; Robert E. Bloch, Anthony E. Harris, Steven B. Kamer, Gregory B. Hovendon, Molly L. Debusschere, Seymour H. Dussman, on brief), for appellants.

William Beverly Poff (Heman A. Marshall, III, Michael F. Urbanski, Woods, Rogers & Hazlegrove; William G. Kopit, Robert W. McCann, Epstein Becker & Green, P.C., on brief), for appellees.

(Thomas Campbell, James W. Teevans, Gardner, Carton & Douglas; C. Scott Sykes, Jr., General Counsel, Voluntary Hospitals of America, Inc., on brief), for amicus curiae Voluntary Hospitals of America, Inc.

(Kirk B. Johnson, General Counsel; Edward B. Hirshfeld, Association General Counsel, on brief), for amicus curiae American Medical Association.

(William D. Iverson, Judith B. Sapp, COVINGTON & BURLING, on brief), for amicus curiae Lewis-Gale Hospital, Inc.

Before HARRISON L. WINTER, K.K. HALL and PHILLIPS, Circuit Judges.

PER CURIAM:

The government instituted this antitrust case to prevent the merger of two nonprofit hospitals in Roanoke, Virginia--Roanoke Memorial Hospital, owned by Carilion Health System, and Community Hospital of Roanoke. There is a third hospital facility in Roanoke, Lewis-Gale Hospital, a for-profit hospital which is owned by Hospital Corporation of America. The suit was brought under § 1 of the Sherman Act, 15 U.S.C. § 1, and § 7 of the Clayton Act, 15 U.S.C. § 18.

The district court dismissed the action under § 7 of the Clayton Act on the ground that it had no application because the merging corporations neither had stock nor were they subject to the jurisdiction of the Federal Trade Commission. It then tried the § 1 cause of action with an advisory jury. The jury found the relevant service or product market to include acute inpatient hospital services and certain outpatient health care services provided by various clinics. The jury found the relevant geographic market to be the Roanoke Valley, defined as the cities of Roanoke and Salem, Roanoke County including the Town of Vinton and adjacent portions of Montgomery, Craig, Floyd, Franklin, Bedford and Botetourt Counties that surround Roanoke County. Finally the jury found that the merger would not substantially reduce competition in the relevant market and would not constitute an unreasonable restraint of trade.

The district court then made its own findings of fact. It rejected the advisory jury's findings as to the relevant product market and the relevant geographic market. The district court's findings as to product market are best stated by a quotation from its opinion:

Various witnesses agreed that some medical needs are treated exclusively on an outpatient basis, while others are treated only in a hospital. Most also agreed, however, that a significant number of problems could be treated either on an in or outpatient basis. Reasonable doctors differ as to when a problem must be treated in a hospital or when outpatient treatment is appropriate. Moreover, various insurance carriers, including Blue Cross and Blue Shield of Virginia, two of whose executives testified at trial, have restructured their reimbursement policies in recent years in order to encourage patients to use outpatient services, which are less expensive than inpatient care. Because patients or their doctors can choose to have problems treated either in a hospital or in an outpatient clinic or doctor's office in a significant number of cases, the court finds that certain clinics and other providers of outpatient services compete with the defendants' hospitals to treat various medical needs.

United States v. Carilion Health System, 707 F.Supp. 840, 844-45 (W.D.Va.1989).

The district court found that the geographic market differed with respect to primary and secondary hospital care as a unit and tertiary hospital services. For the former the geographic area included all places from which Roanoke Memorial Hospital draws at least 100 patients per year. This area is more extensive than the Roanoke Valley area delineated by the advisory jury and includes additional counties in Virginia, some counties in West Virginia and the Virginia cities of Lynchburg, Radford and Galax. The geographic area of tertiary services is even larger. It includes Richmond and Charlottesville, Virginia, and Winston-Salem and Durham, North Carolina.

Finally the district court found that while the record was inadequate to predict the market share of the merged hospitals in the relevant geographic market, financial and legal barriers to the expansion of competition by other health care providers in the market were not so prohibitive that competition would be suppressed. Also the district court found that the intent of the merging corporations to increase their ability to compete indicated the reasonableness of the merger. Accordingly the district court gave judgment for defendants.

The government appeals. It contends that the district court was in error in failing to find that the product market is acute inpatient services and that patients seeking such services cannot feasibly turn to any alternative other than admission to a Roanoke Valley hospital for overnight care. The government also contends that the district court was in error in finding that the relevant geographic market extended beyond the Roanoke Valley, as found by the advisory jury, to include an additional fourteen Virginia and West Virginia counties plus three cities. When the relevant product and geographic markets are correctly defined, the government argues, the merged entity will have in excess of 70% of staffed beds, licensed beds, acute inpatient admissions, acute inpatient days, and acute inpatient gross revenues. This concentration, so the argument runs, makes new market entry unlikely, and thus constitutes a violation of § 1 of the Sherman Act. The government therefore asks that we direct the entry of judgment for it under § 1. Alternatively the government prays that if we conclude that further proceedings in the district court are indicated, we should hold that § 7 of the Clayton Act is applicable to this proposed merger and it too will be violated unless the merger is enjoined. 1

In analyzing the government's challenge to the proposed merger under § 1 of the Sherman Act, we must (1) define the relevant product and geographic markets, (2) determine the market share of the proposed merged entity, and (3) assess the effect on competition and the reasonableness of the merger in light of all the circumstances. Antitrust Div., Department of Justice, Merger Guidelines, 49 Fed.Reg. 26,823 (1984), §§ 2-3. These are factual issues. H.J. Inc. v. ITT, 867 F.2d 1531, 1537 (8 Cir.1989); Oltz v. St. Peter's Community Hosp., 861 F.2d 1440, 1446 (9 Cir.1988). See also International Word Processors v. Power Dry, Inc., 792 F.2d 416, 430-31 (4 Cir.1986). The district court's determination of the product and geographic markets and the effect on competition of the merger is therefore subject to reversal only if clearly erroneous. Anderson v. Bessemer City, N.C., 470 U.S. 564 (1985).

a. Product Market

We have said that product market should include "those products or services...

To continue reading

Request your trial
8 cases
  • Forsyth v. Humana, Inc.
    • United States
    • U.S. District Court — District of Nevada
    • July 21, 1993
    ... ... HUMANA, INC., a Delaware corporation; Humana Health Insurance of Nevada, Inc., a Nevada corporation; and Does I ... 1777, 84 L.Ed.2d 836 (1985); United States v. Carilion Health System, 707 F.Supp. 840, 847 (W.D.Va.1989), aff'd, ... The entire text of (§ 1109) persuades us that Congress did not intend to authorize any relief except ... ...
  • F.T.C. v. University Health, Inc.
    • United States
    • U.S. Court of Appeals — Eleventh Circuit
    • May 6, 1991
    ... ... Act of 1958 ... ; in the Board of Governors of the Federal Reserve System where applicable to banks, banking associations, and trust companies; and ... asset acquisitions. 17 Nonetheless, the appellees ask us to confer a special dispensation upon them, based on their interpretation ... Probs. 93, 112-13 (Spring 1989). But see United States v. Carilion Health Sys., 707 F.Supp. 840, 841 n. 1 (W.D.Va.), aff'd, 892 F.2d 1042 ... ...
  • U.S. v. Long Island Jewish Medical Center, CV 97-3412(ADS).
    • United States
    • U.S. District Court — Eastern District of New York
    • October 23, 1997
    ... ... LONG ISLAND JEWISH MEDICAL CENTER and North Shore Health System, Inc., Defendants ... No. CV 97-3412(ADS) ... " In effect, the MCO says to the hospital, "Give us the right price and you can see the patients." (Tr. at ... Carilion Health System, 707 F.Supp. 840, 842 (W.D.Va.), (relevant ... ...
  • U.S. v. Rockford Memorial Corp., 89-1900
    • United States
    • U.S. Court of Appeals — Seventh Circuit
    • April 3, 1990
    ... ... the loophole that the government rather desperately asks us to fill by a far-out interpretation of section 7. We ... Carilion Health System, 707 F.Supp. 840, 841 n. 1 (W.D.Va.), aff'd ... ...
  • Request a trial to view additional results
26 books & journal articles
  • Chapter II. Mergers
    • United States
    • ABA Archive Editions Library Telecom Antitrust Handbook. Second Edition
    • January 1, 2013
    ...(6th Cir. 1997). Cf . United States v. Carilion Health Sys., 707 F. Supp. 840 (W.D. Va. 1989) (taking cost savings into account), aff’d , 892 F.2d 1042 (4th Cir. 1989). Conversely, where an injunction against a merger would prevent realization of cost savings, the public interest may be har......
  • Table of Cases
    • United States
    • ABA Antitrust Library Telecom Antitrust Handbook. Third Edition
    • December 9, 2019
    ...F.2d 456 (1988), 337 United States v. Carilion Health Sys., 707 F. Supp. 840 (W.D. Va. 1989), 298 United States v. Carilion Health Sys., 892 F.2d 1042 (4th Cir. 1989), 298 United States v. Colgate & Co., 250 U.S. 300 (1919), 144, 180 United States v. Columbia Steel & Co., 334 U.S. 495 (1948......
  • Table of Cases
    • United States
    • ABA Archive Editions Library Mergers and Acquisitions: Understanding the Antitrust Issues, 2d Edition
    • January 1, 2004
    ...F. Supp. 1298 (D.N.J. 1985), 75, 107, 112, 157, 462 United States v. Carilion Health System, 707 F. Supp. 840 (W.D. Va.), aff’d mem ., 892 F.2d 1042 (4th Cir. 1989), 7, 62 United States v. Carrols Development Corp., 454 F. Supp. 1215 (N.D.N.Y. 1978), 482 United States v. Celanese Corp. of A......
  • Overview of the Applicable U.S. Antitrust Laws
    • United States
    • ABA Antitrust Library Mergers and Acquisitions. Understanding the Antitrust Issues. Fourth Edition
    • December 6, 2015
    ...(W.D. Mo.), aff’d , 69 F.3d 260 (8th Cir. 1995). But cf. United States v. Carilion Health Sys., 707 F. Supp. 840 (W.D. Va.), aff’d mem. , 892 F.2d 1042 (4th Cir. 1989). In Carilion , the court dismissed the § 7 claim because the acquisition involved no stock, and therefore was not captured ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT